Back to Search
Start Over
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non–Small Cell Lung Cancer: The Phase II TRUST-I Study.
- Source :
- Journal of Clinical Oncology; 8/1/2024, Vol. 42 Issue 22, p2660-2670, 15p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178686155
- Full Text :
- https://doi.org/10.1200/JCO.24.00731